These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 11740700

  • 1. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus.
    Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, Rubins JB.
    Clin Infect Dis; 2002 Jan 15; 34(2):147-53. PubMed ID: 11740700
    [Abstract] [Full Text] [Related]

  • 2. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

  • 3. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.
    Rheumatology (Oxford); 2006 Jan 12; 45(1):106-11. PubMed ID: 16287919
    [Abstract] [Full Text] [Related]

  • 4. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB.
    Vaccine; 2009 Mar 04; 27(10):1628-36. PubMed ID: 19100304
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.
    Miernyk KM, Butler JC, Bulkow LR, Singleton RJ, Hennessy TW, Dentinger CM, Peters HV, Knutsen B, Hickel J, Parkinson AJ.
    Clin Infect Dis; 2009 Jul 15; 49(2):241-8. PubMed ID: 19522655
    [Abstract] [Full Text] [Related]

  • 6. [Antipneumococcal vaccination in patient with systemic lupus erythematosus].
    Pisoni C, Sarano J, Benchetrit G, Rodríguez D, Suárez L, Perrota C, Manni J.
    Medicina (B Aires); 2003 Jul 15; 63(5):388-92. PubMed ID: 14628647
    [Abstract] [Full Text] [Related]

  • 7. Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies.
    Elkayam O, Paran D, Burke M, Zakut V, Ben-Yitshak R, Litinsky I, Caspi D.
    Autoimmunity; 2005 Nov 15; 38(7):493-6. PubMed ID: 16373254
    [Abstract] [Full Text] [Related]

  • 8. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.
    Brandão AP, de Oliveira TC, de Cunto Brandileone MC, Gonçalves JE, Yara TI, Simonsen V.
    Vaccine; 2004 Dec 21; 23(6):762-8. PubMed ID: 15542200
    [Abstract] [Full Text] [Related]

  • 9. Vaccination and autoimmune rheumatic diseases.
    Conti F, Rezai S, Valesini G.
    Autoimmun Rev; 2008 Dec 21; 8(2):124-8. PubMed ID: 18700175
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
    Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I, Pediatric AIDS Clinical Trials Group P1024 Protocol Team.
    Pediatr Infect Dis J; 2006 Oct 21; 25(10):920-9. PubMed ID: 17006288
    [Abstract] [Full Text] [Related]

  • 11. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
    Stojanovich L.
    Clin Dev Immunol; 2006 Oct 21; 13(2-4):373-5. PubMed ID: 17162380
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus.
    Alyasin S, Adab M, Hosseinpour A, Amin R, Babaei M.
    Iran J Immunol; 2016 Sep 21; 13(3):204-19. PubMed ID: 27671512
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of sequential pneumococcal vaccination in subjects splenectomised for hereditary spherocytosis.
    Stoehr GA, Rose MA, Eber SW, Heidemann K, Schubert R, Zielen S.
    Br J Haematol; 2006 Mar 21; 132(6):788-90. PubMed ID: 16487181
    [Abstract] [Full Text] [Related]

  • 14. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.
    French N, Moore M, Haikala R, Kayhty H, Gilks CF.
    J Infect Dis; 2004 Aug 15; 190(4):707-12. PubMed ID: 15272398
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population.
    Leach AJ, Morris PS, Mackenzie G, McDonnell J, Balloch A, Carapetis J, Tang M.
    Vaccine; 2008 Jul 23; 26(31):3885-91. PubMed ID: 18562052
    [Abstract] [Full Text] [Related]

  • 16. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O, Björkholm M, Konradsen HB, Söderqvist M, Nilsson B, Gustavsson A, Axdorph U, Kalin M, Grimfors G.
    J Intern Med; 2004 Jun 23; 255(6):664-73. PubMed ID: 15147530
    [Abstract] [Full Text] [Related]

  • 17. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.
    Hammitt LL, Bulkow LR, Singleton RJ, Nuorti JP, Hummel KB, Miernyk KM, Zanis C, Whaley M, Romero-Steiner S, Butler JC, Rudolph K, Hennessy TW.
    Vaccine; 2011 Mar 09; 29(12):2287-95. PubMed ID: 21255685
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma.
    Rose MA, Schubert R, Kujumdshiev S, Kitz R, Zielen S.
    Int J Clin Pract; 2006 Nov 09; 60(11):1425-31. PubMed ID: 17073839
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F, Siddiqui AA.
    Clin Chim Acta; 2006 Aug 09; 370(1-2):100-7. PubMed ID: 16513103
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
    Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM.
    Clin Infect Dis; 2001 Jan 15; 32(2):307-10. PubMed ID: 11170924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.